Methylnaltrexone bromide 150 mg
RxNorm 1801510
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1801510 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: methylnaltrexone bromide 150 mg.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDCPrescribable
Semantic Clinical Drug Component (SCDC):
Methylnaltrexone bromide 150 mg
(Atom ID: 12276959)
Patient Education
Methylnaltrexone
Methylnaltrexone is used to treat constipation caused by opioid (narcotic) pain medications in people with chronic (ongoing) pain that is not caused by cancer but may be related to a previous cancer or cancer treatment. Methylnaltrexone is in a class of medications called peripherally acting mu-opioid receptor antagonists. It works by protecting the bowel from the effects of opioid (narcotic) medications.
[Learn More]
* Please review the disclaimer below.